KRISTEN BOLTON: Open Payments
NPI 1275641342 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,331 in 61 payments from 17 companies in 2025. Trend: 2023 $284 · 2024 $1,005 · 2025 $1,331
Food & beverage: $1,331
| Company | Payments | Amount |
|---|---|---|
| Echosens North America, Inc. | 6 | $309 |
| Novo Nordisk Inc | 13 | $239 |
| AstraZeneca Pharmaceuticals LP | 6 | $157 |
| ABBVIE INC. | 11 | $145 |
| Lilly USA, LLC | 6 | $107 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Eisai Inc. | 2 | $47 |
| Astellas Pharma US Inc | 3 | $44 |
| PFIZER INC. | 2 | $39 |
| Currax Pharmaceuticals LLC | 2 | $33 |
Products named: Fibroscan, Wegovy, AIRSUPRA, MOUNJARO, Symbravo, LINZESS, VRAYLAR, Leqembi.
Industry payments across TX — which companies pay providers there.
